370 likes | 387 Views
抗生素的該用與不該用. 衛生署 疾病管制局 中區傳染病防治醫療網 王任賢 指揮官. 問題一 : 有長細菌就要用藥嗎 ?. Ans: 那要看細菌由那裡長出來. From sterile site contaminant pathogen: symptomatic or asymptomatic From potential contaminated site quantitative culture From contaminated site. 問題二 : 沒長細菌就不能用藥嗎 ?. 各種器官感染之微生物學診斷率.
E N D
抗生素的該用與不該用 衛生署 疾病管制局 中區傳染病防治醫療網 王任賢 指揮官
Ans: 那要看細菌由那裡長出來 • From sterile site contaminant pathogen: symptomatic or asymptomatic • From potential contaminated site quantitative culture • From contaminated site
各種器官感染之微生物學診斷率 • Septic shock: 80-90% • Cellulitis: 20-50% • Bacterial meningitis: 60-90% • Infective endocarditis: 60-70% • Acute cholecystitis: 50-70% • Urinary tract infection: 30-40% (B) • Community-acquired pneumonia: 25%
Antimicrobial spectrum of penicillin G • Streptococcus spp. • Anaerobes • Neisseria spp.
Second generation penicillins • Anti-Staphylococcus penicillins Streptococcus, Staphylococcus • Ampicillin and derivatives Streptococcus, anaerobes, Neisseria, E. coli, P. mirabilis, Salmonella, Shigella, H.influenzae, Listeria monocytogenes • Amoxicillin/clavulanic acid (augmentin) Ampicillin/sulbactam (unasyn)
Third generation penicillins • Lilacillin • Ticarcillin • Piperacillin • Piperacillin/tazobactam Ticarcillin/clavulanic acid
First generation cephalosporins • Staphylococcus • Streptococcus • E. coli • P. mirabilis • K. pneumoniae
第一代與第二代cephalosporins的分野Hemophilus influenzae
Antimicrobial tests • Tests that predict the effectiveness of therapy • Tests that monitor the effectiveness of therapy
Gram-positive bacteria Staphylococcus spp. Enterococcus spp. S. pneumoniae Streptococcus spp. other than S. pneumoniae Gram-negative bacteria Enterobacterioceae P. aeruginosa Acinetobacter spp. Haemophilus spp. N. gonorrhoeae V. cholerae 可由紙錠擴散法獲得可靠藥物敏感性測試結果的細菌
Gram-positive bacteria Streptococcus viridans Listeria spp. Corynebacterium spp. Bacillus spp. Nocardia spp. Rhodococcus spp. Lactobacillus spp. Others Gram-negative bacteria N. meningitidis M. catarrhalis Non-aeruginosa Pseudomonas GNFGNBs Campylobacter spp. Aeromonas spp. Others 不能由紙錠擴散法獲得可靠藥物敏感性測試結果的細菌
Staphylococcus spp.的紙錠法判讀準則 • Penicillin-susceptible susceptible to all b-lactam antibiotics • Penicillin-resistant, oxacillin-susceptible resistant to b-lactamase-labile penicillins susceptible to b-lactamase-stable penicillins, cephems, carbapenems, b-lactamase inhibitor combinations • Oxacillin-resistant only susceptible to vancomycin & teicoplanin
Enterobacterioceae的紙錠法藥敏試驗 • Intestinal isolates of Salmonella & Shigella ampicillin a quinolone TMP/SMX • Extraintestinal isolate of Salmonella plus chloramphenicol a third generation cephalosporin • Enterobacter, Citrobacter, and Serratia在治療 過程中極易產生抗藥性,治療過程中同樣的 isolate 亦必須作藥敏試驗
Inducible b-lactamase of GNB • Richmond-Sykes group 1 b-lactamase • Chromosomally mediated • Found in: Enterobacter species Serratia species Citrobacter freundii indole-positive Proteus species Providencia species Morganella species Pseudomonas aeruginosa Acinetobacter baumanii
Acceptable antibiotics in IAI • Community-acquired infections of mild-to-moderate severity monotherapy cefoxitin cefotetan cefmetazole ampicillin-sulbactam ticarcillin-clavulanic acid combination therapy anti-anaerobe plus aminoglycoside
Acceptable of antibiotics in IAI • Severe infection monotherapy carbapenems piperacillin-tazobactam combination therapy anti-anaerobe plus 3rd generation cephalosporin or aminoglycoside clindamycin plus aztreonam ciprofloxacin plus metronidazole
Indications for combination • Pseudomonas group infection • Severe sepsis • Unknown etiology • Mixed infection • Anti-TB treatment
Median SBAs* of ceftazidime with or without amikacin Organism Dose SBA 1 h 6 h K. pneumoniae ceftazidime 2.0 g 1:512 1:64 amikacin 0.5 g 1:32 1:4 ceftazidime 2.0 g + amikacin 0.5 g 1:512 1:64 P. aeruginosa ceftazidime 2.0 g 1:64 1:8 amikacin 0.5 g 1:2 <1:2 ceftazidime 2.0 g + amikacin 0.5 g 1:64 1:8 *: serum bactericidal activity Antimicrob Agents Chemother 1983;23:435-9
抗生素一般使用原則 • 盡量用narrow spectrum的藥物 • 一種細菌用一種藥物治療 • 必須以足量藥物治療 • 最佳治療時間為七至十四天
感冒何時需要使用抗生素? • Bacterial tonsillitis • Bacterial pharyngitis • COPD with acute exacerbation • Pneumonia & bronchopneumonia • Sinusitis & otitis media
那些抗生素用量增加時該查? • 所有口服抗生素 • Tetracyclines • Erythromycins • Quinolones • 第一線 b-lactam 抗生素
Indications for tetracycline • Chlamydial diseases • Rickettsial diseases • Brucellosis • Relapsing fever • Tularemia
用上合適抗生素後發燒不退的原因 • Superinfection • Resistant strain • Abscess formation • Drug fever